Evidence map›Paper›PMID 39436715›Full record

ArticleDiabetes care2024

Risk of Infection in Older Adults With Type 2 Diabetes With Relaxed Glycemic Control.

Kasia J Lipska, Lisa K Gilliam, Catherine Lee, Jennifer Y Liu, Vincent X Liu, Howard H Moffet, Melissa M Parker, Heidi Zapata, Andrew J Karter

Abstract read
In one paragraph

Article in Diabetes care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kasia J LipskaSection of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.ORCID 0000-0002-0348-742X
Lisa K GilliamDiabetes Program, Endocrinology and Internal Medicine, Kaiser Permanente Northern California, South San Francisco Medical Center, South San Francisco, CA.ORCID 0000-0001-7054-1409
Catherine LeeDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.ORCID 0000-0003-0008-9052
Jennifer Y LiuDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.
Vincent X LiuDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.
Howard H MoffetDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.ORCID 0000-0002-8728-774X
Melissa M ParkerDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA.
Heidi ZapataSection of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Andrew J KarterSection of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.ORCID 0000-0001-5527-316X

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Optimizing Medical Decision Making for Older Patients with Type 2 DiabetesR01AG063391 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI HUANG, ELBERT S., KARTER, ANDREW JOHN · 2019 to 2023
$3.2M
Single Cell Characterization of Adipose Tissue in the Setting of HIV and AgingK76AG064548 · NIA · YALE UNIVERSITY · PI ZAPATA, HEIDI J · 2019 to 2023
$1.4M
QBSafe: a randomized trial of a novel intervention to improve care for people living with type 2 diabetes.R01DK129616 · NIDDK · YALE UNIVERSITY · PI LIPSKA, KASIA JOANNA · 2022 to 2024
$840k
Relaxed Glycemic Control and the Risk of Infections in Older Adults with Type 2 DiabetesR56AG074986 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI KARTER, ANDREW JOHN, LIPSKA, KASIA JOANNA · 2022 to 2022
$400k
NCATS NIH HHS UL1 TR001863NIA NIH HHS K76 AG064548NIA NIH HHS P30 AG021342NIA NIH HHS R01 AG063391NIA NIH HHS R01-AG063391NIA NIH HHS R56 AG074986NIDDK NIH HHS P30 DK092924NIDDK NIH HHS R01 DK129616
6 · The paper itself

Abstract

objectiveTo compare the risk of hospitalization for infection among patients who achieve intensive versus relaxed glycemic control. RESEARCH DESIGN AND

methodsThis retrospective cohort study included adults age ≥65 years with type 2 diabetes from an integrated health care delivery system. Negative binomial models were used to estimate incidence rates and relative risk (RR) of hospitalization for infections (respiratory; genitourinary; skin, soft tissue, and bone; and sepsis), comparing two levels of relaxed (hemoglobin A1c [HbA1c] 7% to <8% and 8% to <9%) with intensive (HbA1c 6% to <7%) glycemic control from 1 January 2019 to 1 March 2020.

resultsAmong 103,242 older patients (48.5% with HbA1c 6% to <7%, 35.3% with HbA1c 7% to <8%, and 16.1% with HbA1c 8% to <9%), the rate of hospitalization for infections was 51.3 per 1,000 person-years. Compared with HbA1c 6% to <7%, unadjusted risk of hospitalization for infections was significantly elevated among patients with HbA1c 8% to <9% (RR 1.25; 95% CI 1.13, 1.39) but not among patients with HbA1c 7% to <8% (RR 0.99; 95% CI 0.91, 1.08), and the difference became nonsignificant after adjustment. Across categories of infections, the adjusted RR of hospitalization was significantly higher among patients with HbA1c 8% to <9% only for skin, soft tissue, and bone infection (RR 1.33; 95% CI 1.05, 1.69).

conclusionsOlder patients with type 2 diabetes who achieve relaxed glycemic control levels endorsed by clinical guidelines are not at significantly increased risk of hospitalization for most infections, but HbA1c 8% to <9% is associated with an increased risk of hospitalization for skin, soft tissue, and bone infections.

Indexed as

Diabetes Mellitus, Type 2Glycated HemoglobinGlycemic ControlHospitalizationInfectionsAgedAged, 80 and overBlood GlucoseFemaleHumansMaleRetrospective StudiesBlood GlucoseGlycated Hemoglobin

Identifiers

PMID39436715
PMCPMC11655405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.